Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guowei Zhang

Showing results (261-270 of 351) with videos related to

Pageof 36
Sort By:
Cellular Signalling|March 25, 2022
XRCC5 downregulated by TRIM25 is susceptible for lens epithelial cell apoptosisXinmu Mao, Min Ji, Lihua Kang, et al.
Oncogene|September 18, 2024
NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progressionZhiyi Liu, Qinghe Hu, Qing Luo, et al.
ACS Omega|December 30, 2020
Comprehensive Profiling of Proteome and Ubiquitome Changes in Human Lens Epithelial Cell Line after Ultraviolet-B IrradiationXiaojuan Chen, Pengfei Li, Guowei Zhang, et al.
Cancer Biology & Therapy|March 23, 2018
Mutation abundance affects the therapeutic efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma: A retrospective analysisHuijuan Wang, Mina Zhang, Wanyu Tang, et al.
Annals of Palliative Medicine|April 14, 2021
Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitorPeng Li, Peng Qin, Xiaomin Fu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 29, 2022
Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic AlterationsGuowei Zhang, Ruirui Cheng, Yuanyuan Niu, et al.
Frontiers in Plant Science|April 18, 2024
Thidiazuron combined with cyclanilide modulates hormone pathways and ROS systems in cotton, increasing defoliation at low temperaturesHongmei Shu, Shangwen Sun, Xiaojing Wang, et al.
Frontiers in Pharmacology|April 24, 2024
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancerXiaojuan Zhang, Mina Zhang, Xinyang Du, et al.
Frontiers in Pharmacology|October 12, 2020
Hydroxysafflor Yellow A Exerts Anti-Inflammatory Effects Mediated by SIRT1 in Lipopolysaccharide-Induced Microglia ActivationXiude Qin, Juanjuan Chen, Guowei Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinibXuanxuan Zheng, Guowei Zhang, Peng Li, et al.
Pageof 36

Showing results (261-270 of 351) with videos related to

Sort By:
Pageof 36
Cellular Signalling|March 25, 2022
XRCC5 downregulated by TRIM25 is susceptible for lens epithelial cell apoptosisXinmu Mao, Min Ji, Lihua Kang, et al.
Oncogene|September 18, 2024
NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progressionZhiyi Liu, Qinghe Hu, Qing Luo, et al.
ACS Omega|December 30, 2020
Comprehensive Profiling of Proteome and Ubiquitome Changes in Human Lens Epithelial Cell Line after Ultraviolet-B IrradiationXiaojuan Chen, Pengfei Li, Guowei Zhang, et al.
Cancer Biology & Therapy|March 23, 2018
Mutation abundance affects the therapeutic efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma: A retrospective analysisHuijuan Wang, Mina Zhang, Wanyu Tang, et al.
Annals of Palliative Medicine|April 14, 2021
Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitorPeng Li, Peng Qin, Xiaomin Fu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 29, 2022
Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic AlterationsGuowei Zhang, Ruirui Cheng, Yuanyuan Niu, et al.
Frontiers in Plant Science|April 18, 2024
Thidiazuron combined with cyclanilide modulates hormone pathways and ROS systems in cotton, increasing defoliation at low temperaturesHongmei Shu, Shangwen Sun, Xiaojing Wang, et al.
Frontiers in Pharmacology|April 24, 2024
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancerXiaojuan Zhang, Mina Zhang, Xinyang Du, et al.
Frontiers in Pharmacology|October 12, 2020
Hydroxysafflor Yellow A Exerts Anti-Inflammatory Effects Mediated by SIRT1 in Lipopolysaccharide-Induced Microglia ActivationXiude Qin, Juanjuan Chen, Guowei Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinibXuanxuan Zheng, Guowei Zhang, Peng Li, et al.
Pageof 36